Patent · US Active

Compositions, synthesis, and methods of utilizing arylpiperazine derivatives

US8188076B2 · kind B2 · utility

2Cited by
16References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 26, 2010
Grant dateMay 29, 2012
Priority date
Expiry dateOct 25, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides arylpiperazine derivatives having Formula I which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.